Sanger Heart & Vascular Institute

Charlotte, NC, United States

Sanger Heart & Vascular Institute

Charlotte, NC, United States
SEARCH FILTERS
Time filter
Source Type

Morrisville, NC, May 16, 2017 (GLOBE NEWSWIRE) -- The American Society of Echocardiography (ASE) will host its 28th Annual Scientific Sessions, June 2-6, 2017, at the Baltimore Convention Center, Baltimore, Maryland. The program includes innovative learning opportunities from the basics of clinical imaging, to the most sophisticated advances in microbubble gene delivery, to the determination of the best use of echo in value-driven healthcare. The aim is to translate core concepts and new ideas into applicable frameworks. The Advance Program is online and can be downloaded at ASEScientificSessions.org. In addition, the ASE Courses App is continuously updated with detailed session information. Attendance at this four day conference can fulfill certification and accreditation requirements for general medical education or echo-specific CME/MOC content needs. Geoffrey A. Rose, MD, FASE, from Sanger Heart & Vascular Institute Charlotte, NC, is the program chair and has selected international cardiovascular experts to present to an audience of over 2,000 participants. ASE 2017 has a number of sessions that provide a deeper dive into key areas including cardio-oncology, structural heart disease, and critical care echocardiography. The Value of Echo Summit taking place on Monday, June 5, 10:15 AM - 2:45 PM, will explore the cataclysmic changes in the U.S. healthcare system and provide expert opinions on how best to navigate and thrive in this new environment. This special Summit is focused on helping the entire cardiovascular ultrasound community understand how their practice is impacted. Registered attendees are invited to bring their hospital administrators and service line leaders to this session free of charge. Another feature of the ASE Scientific Sessions is the 2nd annual Echovation Challenge, a competition Monday, June 5 to showcase novel ideas that have the capacity to enhance the workflow efficiency of cardiovascular ultrasound laboratories while maintaining excellence in patient care. Five finalists will present their approaches to streamlining diagnostics for improved medical decision making. Susan E. Wiegers, MD, FASE, Senior Associate Dean of Faculty Affairs at Lewis Katz School of Medicine at Temple University, Philadelphia, PA, and immediate past president of ASE, will present the 28th Annual Edler Lecture “The Point of Care” on Sunday, June 4, 7:30-9:30 AM. “The Evolution of Contrast Echocardiography: A Journey From Diagnostic to Therapeutic Application,” will be presented by Howard M. Leong-Poi, MD, FASE, Head of the Division of Cardiology at St. Michael’s Hospital and Associate Professor of Medicine at the University of Toronto, Toronto, ON, Canada, as the 18th Annual Feigenbaum Lecture, on Monday afternoon during the Young Investigator’s Award competition. Valentin Fuster, MD, PhD, Director of the Zena and Michael A. Wiener Cardiovascular Institute at Mount Sinai Medical Center, New York, NY, and one of the most prominent cardiologists in the world, is a guest lecturer and co-chair of the Vascular Council’s symposium “The Coming Storm: Atherosclerosis Imaging” on Saturday afternoon. ASE 2017 also boasts the largest echo-specific gathering in the world featuring nearly 50 exhibitors presenting new concepts, technology, devices, and research. This year we have a number of first time vendors. Participants can take part in interactive demonstrations to gain firsthand knowledge of how devices work and how they will benefit practices or institutions. Top experts in the field will make daily presentations in the Science & Technology Theater and in “chalk talks” held on the show floor. Nearly 400 posters will be presented featuring cutting-edge research on the latest advances in cardiovascular ultrasound or clinical cases illustrating evolutions in patient care. Moderated poster presentations will take place on Sunday and Monday. ASE is pleased to offer qualified members of the media a complimentary registration. We can help you present interesting news and developments in cardiac ultrasound technology.  Please contact Angie Porter at aporter@asecho.org if you need any additional information, would like to register to cover the event, or if you would like to arrange interviews with our expert faculty or ASE leadership. Onsite media registration is available, but, if possible we would like to prepare for your coverage in advance. As the largest global organization for cardiovascular ultrasound imaging, the American Society of Echocardiography (ASE) is the leader and advocate, setting practice standards and guidelines. Comprised of over 17,000 physicians, sonographers, nurses, and scientists, ASE is a strong voice providing guidance, expertise, and education to its members. The Society has a commitment to improving the practice of ultrasound and imaging of the heart and cardiovascular system for better patient outcomes. For more information about ASE, visit ASEcho.org or the ASE Scientific Sessions visit ASEScientificSessions.org. A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/bd996363-703c-426c-b07b-e64278f5da0a


Morrisville, NC, May 16, 2017 (GLOBE NEWSWIRE) -- The American Society of Echocardiography (ASE) will host its 28th Annual Scientific Sessions, June 2-6, 2017, at the Baltimore Convention Center, Baltimore, Maryland. The program includes innovative learning opportunities from the basics of clinical imaging, to the most sophisticated advances in microbubble gene delivery, to the determination of the best use of echo in value-driven healthcare. The aim is to translate core concepts and new ideas into applicable frameworks. The Advance Program is online and can be downloaded at ASEScientificSessions.org. In addition, the ASE Courses App is continuously updated with detailed session information. Attendance at this four day conference can fulfill certification and accreditation requirements for general medical education or echo-specific CME/MOC content needs. Geoffrey A. Rose, MD, FASE, from Sanger Heart & Vascular Institute Charlotte, NC, is the program chair and has selected international cardiovascular experts to present to an audience of over 2,000 participants. ASE 2017 has a number of sessions that provide a deeper dive into key areas including cardio-oncology, structural heart disease, and critical care echocardiography. The Value of Echo Summit taking place on Monday, June 5, 10:15 AM - 2:45 PM, will explore the cataclysmic changes in the U.S. healthcare system and provide expert opinions on how best to navigate and thrive in this new environment. This special Summit is focused on helping the entire cardiovascular ultrasound community understand how their practice is impacted. Registered attendees are invited to bring their hospital administrators and service line leaders to this session free of charge. Another feature of the ASE Scientific Sessions is the 2nd annual Echovation Challenge, a competition Monday, June 5 to showcase novel ideas that have the capacity to enhance the workflow efficiency of cardiovascular ultrasound laboratories while maintaining excellence in patient care. Five finalists will present their approaches to streamlining diagnostics for improved medical decision making. Susan E. Wiegers, MD, FASE, Senior Associate Dean of Faculty Affairs at Lewis Katz School of Medicine at Temple University, Philadelphia, PA, and immediate past president of ASE, will present the 28th Annual Edler Lecture “The Point of Care” on Sunday, June 4, 7:30-9:30 AM. “The Evolution of Contrast Echocardiography: A Journey From Diagnostic to Therapeutic Application,” will be presented by Howard M. Leong-Poi, MD, FASE, Head of the Division of Cardiology at St. Michael’s Hospital and Associate Professor of Medicine at the University of Toronto, Toronto, ON, Canada, as the 18th Annual Feigenbaum Lecture, on Monday afternoon during the Young Investigator’s Award competition. Valentin Fuster, MD, PhD, Director of the Zena and Michael A. Wiener Cardiovascular Institute at Mount Sinai Medical Center, New York, NY, and one of the most prominent cardiologists in the world, is a guest lecturer and co-chair of the Vascular Council’s symposium “The Coming Storm: Atherosclerosis Imaging” on Saturday afternoon. ASE 2017 also boasts the largest echo-specific gathering in the world featuring nearly 50 exhibitors presenting new concepts, technology, devices, and research. This year we have a number of first time vendors. Participants can take part in interactive demonstrations to gain firsthand knowledge of how devices work and how they will benefit practices or institutions. Top experts in the field will make daily presentations in the Science & Technology Theater and in “chalk talks” held on the show floor. Nearly 400 posters will be presented featuring cutting-edge research on the latest advances in cardiovascular ultrasound or clinical cases illustrating evolutions in patient care. Moderated poster presentations will take place on Sunday and Monday. ASE is pleased to offer qualified members of the media a complimentary registration. We can help you present interesting news and developments in cardiac ultrasound technology.  Please contact Angie Porter at aporter@asecho.org if you need any additional information, would like to register to cover the event, or if you would like to arrange interviews with our expert faculty or ASE leadership. Onsite media registration is available, but, if possible we would like to prepare for your coverage in advance. As the largest global organization for cardiovascular ultrasound imaging, the American Society of Echocardiography (ASE) is the leader and advocate, setting practice standards and guidelines. Comprised of over 17,000 physicians, sonographers, nurses, and scientists, ASE is a strong voice providing guidance, expertise, and education to its members. The Society has a commitment to improving the practice of ultrasound and imaging of the heart and cardiovascular system for better patient outcomes. For more information about ASE, visit ASEcho.org or the ASE Scientific Sessions visit ASEScientificSessions.org. A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/bd996363-703c-426c-b07b-e64278f5da0a


Morrisville, NC, May 16, 2017 (GLOBE NEWSWIRE) -- The American Society of Echocardiography (ASE) will host its 28th Annual Scientific Sessions, June 2-6, 2017, at the Baltimore Convention Center, Baltimore, Maryland. The program includes innovative learning opportunities from the basics of clinical imaging, to the most sophisticated advances in microbubble gene delivery, to the determination of the best use of echo in value-driven healthcare. The aim is to translate core concepts and new ideas into applicable frameworks. The Advance Program is online and can be downloaded at ASEScientificSessions.org. In addition, the ASE Courses App is continuously updated with detailed session information. Attendance at this four day conference can fulfill certification and accreditation requirements for general medical education or echo-specific CME/MOC content needs. Geoffrey A. Rose, MD, FASE, from Sanger Heart & Vascular Institute Charlotte, NC, is the program chair and has selected international cardiovascular experts to present to an audience of over 2,000 participants. ASE 2017 has a number of sessions that provide a deeper dive into key areas including cardio-oncology, structural heart disease, and critical care echocardiography. The Value of Echo Summit taking place on Monday, June 5, 10:15 AM - 2:45 PM, will explore the cataclysmic changes in the U.S. healthcare system and provide expert opinions on how best to navigate and thrive in this new environment. This special Summit is focused on helping the entire cardiovascular ultrasound community understand how their practice is impacted. Registered attendees are invited to bring their hospital administrators and service line leaders to this session free of charge. Another feature of the ASE Scientific Sessions is the 2nd annual Echovation Challenge, a competition Monday, June 5 to showcase novel ideas that have the capacity to enhance the workflow efficiency of cardiovascular ultrasound laboratories while maintaining excellence in patient care. Five finalists will present their approaches to streamlining diagnostics for improved medical decision making. Susan E. Wiegers, MD, FASE, Senior Associate Dean of Faculty Affairs at Lewis Katz School of Medicine at Temple University, Philadelphia, PA, and immediate past president of ASE, will present the 28th Annual Edler Lecture “The Point of Care” on Sunday, June 4, 7:30-9:30 AM. “The Evolution of Contrast Echocardiography: A Journey From Diagnostic to Therapeutic Application,” will be presented by Howard M. Leong-Poi, MD, FASE, Head of the Division of Cardiology at St. Michael’s Hospital and Associate Professor of Medicine at the University of Toronto, Toronto, ON, Canada, as the 18th Annual Feigenbaum Lecture, on Monday afternoon during the Young Investigator’s Award competition. Valentin Fuster, MD, PhD, Director of the Zena and Michael A. Wiener Cardiovascular Institute at Mount Sinai Medical Center, New York, NY, and one of the most prominent cardiologists in the world, is a guest lecturer and co-chair of the Vascular Council’s symposium “The Coming Storm: Atherosclerosis Imaging” on Saturday afternoon. ASE 2017 also boasts the largest echo-specific gathering in the world featuring nearly 50 exhibitors presenting new concepts, technology, devices, and research. This year we have a number of first time vendors. Participants can take part in interactive demonstrations to gain firsthand knowledge of how devices work and how they will benefit practices or institutions. Top experts in the field will make daily presentations in the Science & Technology Theater and in “chalk talks” held on the show floor. Nearly 400 posters will be presented featuring cutting-edge research on the latest advances in cardiovascular ultrasound or clinical cases illustrating evolutions in patient care. Moderated poster presentations will take place on Sunday and Monday. ASE is pleased to offer qualified members of the media a complimentary registration. We can help you present interesting news and developments in cardiac ultrasound technology.  Please contact Angie Porter at aporter@asecho.org if you need any additional information, would like to register to cover the event, or if you would like to arrange interviews with our expert faculty or ASE leadership. Onsite media registration is available, but, if possible we would like to prepare for your coverage in advance. As the largest global organization for cardiovascular ultrasound imaging, the American Society of Echocardiography (ASE) is the leader and advocate, setting practice standards and guidelines. Comprised of over 17,000 physicians, sonographers, nurses, and scientists, ASE is a strong voice providing guidance, expertise, and education to its members. The Society has a commitment to improving the practice of ultrasound and imaging of the heart and cardiovascular system for better patient outcomes. For more information about ASE, visit ASEcho.org or the ASE Scientific Sessions visit ASEScientificSessions.org. A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/bd996363-703c-426c-b07b-e64278f5da0a


Morrisville, NC, May 16, 2017 (GLOBE NEWSWIRE) -- The American Society of Echocardiography (ASE) will host its 28th Annual Scientific Sessions, June 2-6, 2017, at the Baltimore Convention Center, Baltimore, Maryland. The program includes innovative learning opportunities from the basics of clinical imaging, to the most sophisticated advances in microbubble gene delivery, to the determination of the best use of echo in value-driven healthcare. The aim is to translate core concepts and new ideas into applicable frameworks. The Advance Program is online and can be downloaded at ASEScientificSessions.org. In addition, the ASE Courses App is continuously updated with detailed session information. Attendance at this four day conference can fulfill certification and accreditation requirements for general medical education or echo-specific CME/MOC content needs. Geoffrey A. Rose, MD, FASE, from Sanger Heart & Vascular Institute Charlotte, NC, is the program chair and has selected international cardiovascular experts to present to an audience of over 2,000 participants. ASE 2017 has a number of sessions that provide a deeper dive into key areas including cardio-oncology, structural heart disease, and critical care echocardiography. The Value of Echo Summit taking place on Monday, June 5, 10:15 AM - 2:45 PM, will explore the cataclysmic changes in the U.S. healthcare system and provide expert opinions on how best to navigate and thrive in this new environment. This special Summit is focused on helping the entire cardiovascular ultrasound community understand how their practice is impacted. Registered attendees are invited to bring their hospital administrators and service line leaders to this session free of charge. Another feature of the ASE Scientific Sessions is the 2nd annual Echovation Challenge, a competition Monday, June 5 to showcase novel ideas that have the capacity to enhance the workflow efficiency of cardiovascular ultrasound laboratories while maintaining excellence in patient care. Five finalists will present their approaches to streamlining diagnostics for improved medical decision making. Susan E. Wiegers, MD, FASE, Senior Associate Dean of Faculty Affairs at Lewis Katz School of Medicine at Temple University, Philadelphia, PA, and immediate past president of ASE, will present the 28th Annual Edler Lecture “The Point of Care” on Sunday, June 4, 7:30-9:30 AM. “The Evolution of Contrast Echocardiography: A Journey From Diagnostic to Therapeutic Application,” will be presented by Howard M. Leong-Poi, MD, FASE, Head of the Division of Cardiology at St. Michael’s Hospital and Associate Professor of Medicine at the University of Toronto, Toronto, ON, Canada, as the 18th Annual Feigenbaum Lecture, on Monday afternoon during the Young Investigator’s Award competition. Valentin Fuster, MD, PhD, Director of the Zena and Michael A. Wiener Cardiovascular Institute at Mount Sinai Medical Center, New York, NY, and one of the most prominent cardiologists in the world, is a guest lecturer and co-chair of the Vascular Council’s symposium “The Coming Storm: Atherosclerosis Imaging” on Saturday afternoon. ASE 2017 also boasts the largest echo-specific gathering in the world featuring nearly 50 exhibitors presenting new concepts, technology, devices, and research. This year we have a number of first time vendors. Participants can take part in interactive demonstrations to gain firsthand knowledge of how devices work and how they will benefit practices or institutions. Top experts in the field will make daily presentations in the Science & Technology Theater and in “chalk talks” held on the show floor. Nearly 400 posters will be presented featuring cutting-edge research on the latest advances in cardiovascular ultrasound or clinical cases illustrating evolutions in patient care. Moderated poster presentations will take place on Sunday and Monday. ASE is pleased to offer qualified members of the media a complimentary registration. We can help you present interesting news and developments in cardiac ultrasound technology.  Please contact Angie Porter at aporter@asecho.org if you need any additional information, would like to register to cover the event, or if you would like to arrange interviews with our expert faculty or ASE leadership. Onsite media registration is available, but, if possible we would like to prepare for your coverage in advance. As the largest global organization for cardiovascular ultrasound imaging, the American Society of Echocardiography (ASE) is the leader and advocate, setting practice standards and guidelines. Comprised of over 17,000 physicians, sonographers, nurses, and scientists, ASE is a strong voice providing guidance, expertise, and education to its members. The Society has a commitment to improving the practice of ultrasound and imaging of the heart and cardiovascular system for better patient outcomes. For more information about ASE, visit ASEcho.org or the ASE Scientific Sessions visit ASEScientificSessions.org. A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/bd996363-703c-426c-b07b-e64278f5da0a


PubMed | Clinical Trials Center, Ohio State University, Reid Heart Center, Helios Amper Klinikum and 5 more.
Type: Journal Article | Journal: The American journal of cardiology | Year: 2016

We sought to examine the relation between various degrees of renal function and coronary plaque morphology by grayscale and virtual histology intravascular ultrasound (IVUS). ADAPT-DES was a prospective, multicenter registry of 8,582 consecutive patients treated using coronary drug-eluting stents with a prespecified grayscale and virtual histology-IVUS substudy. A lesion-level analysis of study participants was performed by comparing IVUS parameters of culprit and nonculprit lesions across tertiles of estimated creatinine clearance (CrCl). Preintervention IVUS imaging of 762 patients identified 898 culprit and 752 nonculprit native coronary artery lesions. Patients in the lowest CrCl tertile were older, more often women, and more often presented with stable angina. Compared with the middle and upper tertiles, the lowest tertile was significantly associated with culprit lesion smaller mean external elastic membrane cross-sectional area (12.9 vs 14.2mm


Fargnoli A.S.,Sanger Heart & Vascular Institute | Fargnoli A.S.,University of Pennsylvania | Katz M.G.,Sanger Heart & Vascular Institute | Williams R.D.,Sanger Heart & Vascular Institute | And 2 more authors.
Journal of Cardiovascular Translational Research | Year: 2014

This study evaluates needleless liquid jet method and compares it with three common experimental methods: (1) intramuscular injection (IM), (2) left ventricular intracavitary infusion (LVIC), and (3) LV intracavitary infusion with aortic and pulmonary occlusion (LVIC-OCCL). Two protocols were executed. First (n = 24 rats), retention of dye was evaluated 10 min after delivery in an acute model. The acute study revealed the following: significantly higher dye retention (expressed as % myocardial cross-section area) in the left ventricle in both the liquid jet [52 ± 4] % and LVIC-OCCL [58 ± 3] % groups p < 0.05 compared with IM [31 ± 8] % and LVIC [35 ± 4] %. In the second (n = 16 rats), each animal received adeno-associated virus encoding green fluorescent protein (AAV.EGFP) at a single dose with terminal 6-week endpoint. In the second phase with AAV.EGFP at 6 weeks post-delivery, a similar trend was found with liquid jet [54 ± 5] % and LVIC-OCCL [60 ± 8] % featuring more LV expression as compared with IM [30 ± 9] % and LVIC [23 ± 9] %. The IM and LVIC-OCCL cross sections revealed myocardial fibrosis. With more detailed development in future model studies, needleless liquid jet delivery offers a promising strategy to improve direct myocardial delivery. © 2014, Springer Science+Business Media New York.

Loading Sanger Heart & Vascular Institute collaborators
Loading Sanger Heart & Vascular Institute collaborators